These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 29714413

  • 1. [Expression of AXL enhances docetaxel-resistance of prostate cancer cells].
    Lin JZ, Zhu JG, Wu HF, Li JM, DE W, Wang ZJ.
    Zhonghua Nan Ke Xue; 2017 Apr; 23(4):302-308. PubMed ID: 29714413
    [Abstract] [Full Text] [Related]

  • 2. Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer.
    Lin JZ, Wang ZJ, De W, Zheng M, Xu WZ, Wu HF, Armstrong A, Zhu JG.
    Oncotarget; 2017 Jun 20; 8(25):41064-41077. PubMed ID: 28455956
    [Abstract] [Full Text] [Related]

  • 3. A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors.
    Mahadevan D, Cooke L, Riley C, Swart R, Simons B, Della Croce K, Wisner L, Iorio M, Shakalya K, Garewal H, Nagle R, Bearss D.
    Oncogene; 2007 Jun 07; 26(27):3909-19. PubMed ID: 17325667
    [Abstract] [Full Text] [Related]

  • 4. Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.
    Mishra A, Wang J, Shiozawa Y, McGee S, Kim J, Jung Y, Joseph J, Berry JE, Havens A, Pienta KJ, Taichman RS.
    Mol Cancer Res; 2012 Jun 07; 10(6):703-12. PubMed ID: 22516347
    [Abstract] [Full Text] [Related]

  • 5. Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells.
    Bansal N, Mishra PJ, Stein M, DiPaola RS, Bertino JR.
    Oncotarget; 2015 Jun 20; 6(17):15321-31. PubMed ID: 26036314
    [Abstract] [Full Text] [Related]

  • 6. microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73.
    Gao Q, Zheng J.
    Biomed Pharmacother; 2018 Jan 20; 97():528-534. PubMed ID: 29091904
    [Abstract] [Full Text] [Related]

  • 7. The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance.
    Toner AP, McLaughlin F, Giles FJ, Sullivan FJ, O'Connell E, Carleton LA, Breen L, Dunne G, Gorman AM, Lewis JD, Glynn SA.
    Br J Cancer; 2013 Oct 15; 109(8):2131-41. PubMed ID: 24052043
    [Abstract] [Full Text] [Related]

  • 8. siRNA-mediated silencing of Notch-1 enhances docetaxel induced mitotic arrest and apoptosis in prostate cancer cells.
    Ye QF, Zhang YC, Peng XQ, Long Z, Ming YZ, He LY.
    Asian Pac J Cancer Prev; 2012 Oct 15; 13(6):2485-9. PubMed ID: 22938409
    [Abstract] [Full Text] [Related]

  • 9. BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer.
    Crea F, Duhagon Serrat MA, Hurt EM, Thomas SB, Danesi R, Farrar WL.
    Int J Cancer; 2011 Apr 15; 128(8):1946-54. PubMed ID: 20568112
    [Abstract] [Full Text] [Related]

  • 10. Characterisation and manipulation of docetaxel resistant prostate cancer cell lines.
    O'Neill AJ, Prencipe M, Dowling C, Fan Y, Mulrane L, Gallagher WM, O'Connor D, O'Connor R, Devery A, Corcoran C, Rani S, O'Driscoll L, Fitzpatrick JM, Watson RW.
    Mol Cancer; 2011 Oct 07; 10():126. PubMed ID: 21982118
    [Abstract] [Full Text] [Related]

  • 11. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G1 Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone Marrow.
    Lee E, Decker AM, Cackowski FC, Kana LA, Yumoto K, Jung Y, Wang J, Buttitta L, Morgan TM, Taichman RS.
    J Cell Biochem; 2016 Dec 07; 117(12):2815-2824. PubMed ID: 27153245
    [Abstract] [Full Text] [Related]

  • 12. Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor.
    Sainaghi PP, Castello L, Bergamasco L, Galletti M, Bellosta P, Avanzi GC.
    J Cell Physiol; 2005 Jul 07; 204(1):36-44. PubMed ID: 15605394
    [Abstract] [Full Text] [Related]

  • 13. CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
    Gioia R, Trégoat C, Dumas PY, Lagarde V, Prouzet-Mauléon V, Desplat V, Sirvent A, Praloran V, Lippert E, Villacreces A, Leconet W, Robert B, Vigon I, Roche S, Mahon FX, Pasquet JM.
    J Pathol; 2015 Sep 07; 237(1):14-24. PubMed ID: 25965880
    [Abstract] [Full Text] [Related]

  • 14. Mistletoe (Viscum album) extract targets Axl to suppress cell proliferation and overcome cisplatin- and erlotinib-resistance in non-small cell lung cancer cells.
    Kim S, Kim KC, Lee C.
    Phytomedicine; 2017 Dec 01; 36():183-193. PubMed ID: 29157814
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of gefitinib‑celecoxib combination therapy in docetaxel‑resistant prostate cancer.
    Lin JZ, Hameed I, Xu Z, Yu Y, Ren ZY, Zhu JG.
    Oncol Rep; 2018 Oct 01; 40(4):2242-2250. PubMed ID: 30066906
    [Abstract] [Full Text] [Related]

  • 16. Mechanism research of miR-34a regulates Axl in non-small-cell lung cancer with gefitinib-acquired resistance.
    Xiong R, Sun XX, Wu HR, Xu GW, Wang GX, Sun XH, Xu MQ, Xie MR.
    Thorac Cancer; 2020 Jan 01; 11(1):156-165. PubMed ID: 31777195
    [Abstract] [Full Text] [Related]

  • 17. HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo.
    Ikezoe T, Hisatake Y, Takeuchi T, Ohtsuki Y, Yang Y, Said JW, Taguchi H, Koeffler HP.
    Cancer Res; 2004 Oct 15; 64(20):7426-31. PubMed ID: 15492266
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
    Lv F, Yu Y, Zhang B, Liang D, Li ZM, You W.
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec 15; 33(6):870-876. PubMed ID: 24337851
    [Abstract] [Full Text] [Related]

  • 19. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
    Wang Y, Lieberman R, Pan J, Zhang Q, Du M, Zhang P, Nevalainen M, Kohli M, Shenoy NK, Meng H, You M, Wang L.
    Mol Cancer; 2016 Nov 10; 15(1):70. PubMed ID: 27832783
    [Abstract] [Full Text] [Related]

  • 20. Developmentally regulated GTP-binding protein 2 levels in prostate cancer cell lines impact docetaxel-induced apoptosis.
    Kim SC, Lee WH, Kim SH, Abdulkhayevich AA, Park JW, Kim YM, Moon KH, Lee SH, Park S.
    Investig Clin Urol; 2021 Jul 10; 62(4):485-495. PubMed ID: 34190439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.